Pharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company’s products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming’s technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company’s commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.
|Size (employees)||94 (est)|
When was Pharming Group founded?
Pharming Group was founded in 1988.
How many employees does Pharming Group have?
Pharming Group has 94 employees.
Who are Pharming Group competitors?
Competitors of Pharming Group include Keryx Biopharmaceuticals, NovaBay Pharmaceuticals and Chiasma.
Where is Pharming Group headquarters?
Pharming Group headquarters is located at 24 Darwinweg, Leiden.
Where are Pharming Group offices?
Pharming Group has an office in Leiden.
How many offices does Pharming Group have?
Pharming Group has 1 office.